Comparison of the Efficacy and Safety of Fixed-rate Basal Infusion Mode and Time-programmed Decremental Background Infusion Mode of Intravenous PCA Following Mixed Surgery
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Fixed-rate basal infusion mode, Time-programmed decremental background infusion mode.
- Кому может быть актуально
- Состояния в реестре: Surgery, Pain Management, Opioid Consumption, Patient Controlled Analgesia. Базовые параметры: 18 лет — 65 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Китай
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Prospective Randomized Controlled Study of Individualized PCA Model Based on Multi-dimensional Strategies (Fixed-rate Basal Infusion Mode and Time-programmed Decremental Background Infusion Mode)
Обзор
Perioperative pain management affects patient recovery. However, the rate of moderate to severe postoperative pain is as high as 73.8%, which hinders recovery and increases the risk of complications. Although opioids are the first-line analgesics, excessive use leads to adverse reactions. The traditional fixed-rate PCA mode is difficult to match the changes in postoperative pain. This study will compare different PCA mode optimization strategies, assuming that they can reduce opioid dosage, improve analgesic effect, and reduce adverse reactions, providing high-quality evidence-based basis for postoperative analgesia and promoting individualized and intelligent management.
Подробное описание
Perioperative pain management significantly impacts patient recovery outcomes. However, the incidence of moderate to severe postoperative pain remains high at 73.8%, which impedes recovery and increases complication risks. Although opioids serve as first-line analgesics, excessive use causes numerous adverse reactions. The traditional fixed-rate Patient-Controlled Analgesia (PCA) mode fails to adapt to dynamic postoperative pain variations. This study will compare different PCA optimization strategies, hypothesizing that these approaches can reduce opioid dosage, enhance analgesic effectiveness, and minimize adverse reactions. The research aims to provide evidence-based foundations for postoperative analgesia, promoting individualized and intelligent pain management systems that better serve patient needs throughout recovery.
Вмешательства
- Процедура Fixed-rate basal infusion mode
All participants received a standardized PCA solution containing sufentanil (200 μg), ondansetron (32 mg), and normal saline with total volume 200 mL. In conventional fixed-rate basal infusion mode group, the PCA was set to administer a bolus of 2 mL with a lock out interval of 15 minutes and background infusion rate 2 mL/h. - Процедура Time-programmed decremental background infusion mode
In the time-programmed decremental infusion group, which served as the intervention group, the bolus dose and lockout interval will remain the same, whereas the background infusion rate will be reduced according to a predefined postoperative schedule designed to match the expected decline in postoperative pain intensity. Specifically, the background infusion rate will be set at 4.0 mL/h during the first 6 postoperative hours, reduced to 3 mL/h from 6 to 12 hours, decreased to 2.0 mL/h from 12 to
Первичные конечные точки
- Cumulative opioid consumption [Срок оценки: Within the first 48 hours postoperatively]
Вторичные конечные точки (10)
- Resting and movement pain score was assessed by numeric rating scale. [Срок оценки: At 1, 6, 12, 24, and 48 hours postoperatively]
- Cumulative patient-controlled analgesia volume consumption [Срок оценки: Within the first 48 hours postoperatively]
- Frequency of additional rescue analgesics [Срок оценки: At 1, 6, 12, 24, and 48 hours postoperatively]
- Dosage of additional rescue analgesics [Срок оценки: At 1, 6, 12, 24, and 48 hours postoperatively]
- Bolus demand frequency [Срок оценки: at 1, 6, 12, 24, and 48 hours postoperatively]
- Postoperative quality of recovery [Срок оценки: At 24, and 48 hours postoperatively]
- Quality of sleep [Срок оценки: At 24, and 48 hours postoperatively]
- The level of sedation and agitation [Срок оценки: At 1, 6, 12, 24, and 48 hours postoperatively]
- The degree of nausea and vomiting [Срок оценки: At 1, 6, 12, 24, and 48 hours postoperatively]
- The patient's satisfaction with patient-controlled analegsia device [Срок оценки: At 48 hours postoperatively]
Критерии участия
Критерии включения
- aged between 18 to 65 years;
- American Society of Anesthesiologists physical status Ⅰ - Ⅲ;
- Patients scheduled for elective mixed surgery were enrolled. Mixed surgeries included thoracoscopic surgery, laparoscopic surgery, hysteroscopy surgery, laparotomy, thoracotomy, open spinal surgery, craniotomy, and so on.
Критерии исключения
- Chronic pain syndromes;
- Psychiatric disorders;
- Severe cardiovascular or cerebrovascular disease, renal or hepatic functional dysfunction, or allergic to PCA medications.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Четверное слепое
- Основная цель
- Лечение
Центры проведения
Китай · 1 центр
- Beijing Tiantan Hospital, Beijing, Beijing 100070 — Пекин
Публикации
- Ma Y, Liu M, Sun H, Luo F, Wan L. Comparison of Cumulative Opioid Consumption Between Time-Programmed Decremental Infusion and Fixed-Rate Basal Infusion Modes of Intravenous Patient-Controlled Analgesia Following Mixed Surgery: Protocol for a Randomized Controlled Trial. J Pain Res. 2026 Jun 4;19:613446. doi: 10.2147/JPR.S613446. eCollection 2026. PMID 42272993
Идентификаторы
NCT: NCT07375121 · KY2025-387-02-2